Publications by authors named "Roberto Carando"

Claim this Profile
P
Prognostic Implications of Patients With Clinically Node Positive Bladder Cancer Undergoing Radical Cystectomy.
Pietro Scilipoti, Marco Moschini, Paolo Zaurito, Mattia Longoni, Mario De Angelis, Roberto Carando

Clin Genitourin Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder Cancer.
Pietro Scilipoti, Marco Moschini, Mario de Angelis, Mattia Longoni, Luca Afferi, Roberto Carando

Clin Genitourin Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of re-transurethral resection of bladder tumor in patients with TaHG non muscle invasive bladder cancer.
Pietro Scilipoti, Marco Moschini, Mario de Angelis, Luca Afferi, Chiara Lonati, Roberto Carando

World J Urol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications for diagnosis and treatment strategies in non-muscle invasive bladder cancer with variant histology: a systematic review.
Giuseppe Basile, Mario de Angelis, Riccardo Leni, Chiara Re, Mattia Longoni, Roberto Carando

Minerva Urol Nephrol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electromotive Drug Administration of Mitomycin C (EMDA/MMC) versus Intravesical Immunotherapy with Bacillus Calmette-Guérin (BCG) in Intermediate and High Risk Non Muscle Invasive Bladder Cancer.
Michele Zazzara, Arjan Nazaraj, Marcello Scarcia, Giuseppe Cardo, Roberto Carando

Urol Int· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer.
Luca Afferi, Chiara Lonati, Francesco Montorsi, Alberto Briganti, Andrea Necchi, Roberto Carando

Eur Urol Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bladder perforation during transurethral resection of the bladder: a comprehensive algorithm for diagnosis, management and follow-up.
Chiara Lonati, Francesco Esperto, Roberto M Scarpa, Rocco Papalia, Juan Gómez Rivas, Roberto Carando

Minerva Urol Nephrol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration.
Chiara Lonati, Philipp Baumeister, Luca Afferi, Andrea Mari, Andrea Minervini, Roberto Carando

Eur Urol Focus· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant chemotherapy does not increase peri-operative morbidity following radical cystectomy.
Amandeep Arora, Ahmed S Zugail, Felipe Pugliesi, Xavier Cathelineau, Petr Macek, Roberto Carando

World J Urol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Prior Bladder Cancer on Recurrence in Patients Treated with Radical Nephroureterectomy.
Alberto Martini, Chiara Lonati, Francesco Montorsi, Alberto Briganti, Renzo Colombo, Roberto Carando

Clin Genitourin Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancer.
Luca Afferi, Chiara Lonati, Francesco Montorsi, Alberto Briganti, Andrea Necchi, Roberto Carando

World J Urol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variant histologies in bladder cancer: Does the centre have an impact in detection accuracy?
Alessia Cimadamore, Chiara Lonati, Ettore Di Trapani, Ottavio De Cobelli, Michael Rink, Roberto Carando

Urol Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous bladder cancer: an international multi-centre collaboration.
Chiara Lonati, Luca Afferi, Andrea Mari, Andrea Minervini, Wojciech Krajewski, Roberto Carando

World J Urol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic accuracy of preoperative lymph node staging of bladder cancer according to different lymph node locations: A multicenter cohort from the European Association of Urology - Young Academic Urologists.
Chiara Lonati, Livio Mordasini, Luca Afferi, Ottavio De Cobelli, Ettore Di Trapani, Roberto Carando

Urol Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Primary Tumor Location on Long-Term Oncological Outcomes in Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy: A Systematic Review and Meta-Analysis.
Wojciech Krajewski, Łukasz Nowak, Bartosz Małkiewicz, Joanna Chorbińska, Paweł Kiełb, Roberto Carando

J Pers Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nephron sparing surgery for the treatment of renal masses: A single center experience.
Michele Zazzara, Roberto Carando, Arjan Nazaraj, Marcello Scarcia, Michele Romano

Urologia· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision medicine in localized bladder cancer: Personalizing therapies to improve outcomes.
Roberto Carando, Giuseppe Mario Ludovico, Michele Zazzara, Stefania Zamboni, Luca Afferi

Arch Esp Urol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electro-mediated drug administration of mitomycin C in preventing non-muscle-invasive bladder cancer recurrence and progression after transurethral resection of the bladder tumour in intermediate- and high-risk patients.
Roberto Carando, Emiliano Soldini, Simone Cotrufo, Michele Zazzara, Giuseppe M Ludovico

Arab J Urol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ureteral and urethral recurrence after radical cystectomy: a systematic review.
Roberto Carando, Shahrokh F Shariat, Marco Moschini, David D'Andrea

Curr Opin Urol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effectiveness of multiparametric magnetic resonance imaging in bladder cancer (Vesical Imaging-Reporting and Data System): A systematic review.
Roberto Carando, Luca Afferi, Giancarlo Marra, Wojciech Krajewski, Vincenzo Pagliarulo

Arab J Urol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravesical Treatment with Electro-Mediated Administration of Mytomicin C as Prophylaxis for Intermediate and High-Risk Nonmuscle-Invasive Bladder Cancer: A Retrospective Multicenter Study.
Roberto Carando, Michele Zazzara, Simone Cotrufo, Giuseppe M Ludovico

Urol Int· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Mitoxantrone chemoprophylaxis for multirecurrent multifocal superficial bladder tumours: results of a phase 2 controlled study].
Pier Francesco Bassi, Renato Spinadin, Roberto Carando, Fabrizio Dal Moro, Giuseppe Abatangelo

Arch Ital Urol Androl· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis